Skip to main content
Erschienen in: Inflammation 5/2017

27.06.2017 | ORIGINAL ARTICLE

IL-22 Enhances TNF-α- and IL-1-Induced CXCL8 Responses by Intestinal Epithelial Cell Lines

verfasst von: Rebecca S. Young, Brody M. Wiles, Dennis W. McGee

Erschienen in: Inflammation | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

IL-22 is known to induce intestinal epithelial cells (IECs) to produce the chemokine CXCL8. However, IECs exist in a cytokine network during mucosal inflammation, such that IL-22 must act in concert with potent pro-inflammatory cytokines like TNF-α and IL-1. Our studies show that IL-22 alone increased CXCL8 secretion from HT-29 cells, but the levels were minimal compared to that of the cells treated with TNF-α or IL-1 only. More significantly, co-stimulation with IL-22 and TNF-α enhanced both CXCL8 secretion and mRNA levels well over that of TNF-α stimulation alone. A similar enhancing effect was seen with IL-22- and IL-1-stimulated CXCL8 secretion. The enhancing effect of IL-22 on TNF-α-induced CXCL8 secretion was then determined to require the p38 MAPK, but not STAT1/3, PI3K, Akt, c-Jun N-terminal kinase, ERK, or IκBα. These experiments indicate that more significant effect of IL-22 on IECs responses may not be in inducing CXCL8 by itself, but in enhancing TNF-α- and IL-1-induced CXCL8 secretion to augment the contribution of IECs to local inflammatory responses.
Literatur
2.
Zurück zum Zitat Henderson, P., J.E. van Limbergen, J. Schwarze, and D.C. Wilson. 2011. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease. Inflammatory Bowel Disease 17: 382–395.CrossRef Henderson, P., J.E. van Limbergen, J. Schwarze, and D.C. Wilson. 2011. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease. Inflammatory Bowel Disease 17: 382–395.CrossRef
3.
Zurück zum Zitat Jung, H.C., L. Eckmann, S.-K. Yang S-K, A. Panja, J. Fierer, E. Morzycka-Wroblewska, and M.F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. Journal of Clinical Investigation 95: 55–65.CrossRefPubMedPubMedCentral Jung, H.C., L. Eckmann, S.-K. Yang S-K, A. Panja, J. Fierer, E. Morzycka-Wroblewska, and M.F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. Journal of Clinical Investigation 95: 55–65.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Onyiah, J.C., and S.P. Colgan. 2016. Cytokine responses and epithelial function in the intestinal mucosa. Cellular and Molecular Life Sciences 73: 4203–3212.CrossRefPubMed Onyiah, J.C., and S.P. Colgan. 2016. Cytokine responses and epithelial function in the intestinal mucosa. Cellular and Molecular Life Sciences 73: 4203–3212.CrossRefPubMed
5.
Zurück zum Zitat Murch, S.H., C.P. Braegger, J.A. Walker-Smith, and T.T. MacDonald. 1993. Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease. Gut 34: 1705–1709.CrossRefPubMedPubMedCentral Murch, S.H., C.P. Braegger, J.A. Walker-Smith, and T.T. MacDonald. 1993. Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease. Gut 34: 1705–1709.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Reinecker, H.C., M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R.P. MacDermott, and A. Raedler. 1993. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease. Clinical and Experimental Immunology 94: 174–181.CrossRefPubMedPubMedCentral Reinecker, H.C., M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R.P. MacDermott, and A. Raedler. 1993. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease. Clinical and Experimental Immunology 94: 174–181.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ouyang, W., S. Rutz, N.K. Crellin, P.A. Valdez, and S.G. Hymowitz. 2011. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology 29: 71–109.CrossRefPubMed Ouyang, W., S. Rutz, N.K. Crellin, P.A. Valdez, and S.G. Hymowitz. 2011. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology 29: 71–109.CrossRefPubMed
8.
Zurück zum Zitat Dudakov, J.A., A.M. Hanash, and M.R.M. van den Brink. 2015. Interleukin-22: Immunobiology and pathology. Annual Review of Immunology 33: 747–785.CrossRefPubMedPubMedCentral Dudakov, J.A., A.M. Hanash, and M.R.M. van den Brink. 2015. Interleukin-22: Immunobiology and pathology. Annual Review of Immunology 33: 747–785.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Brand, S., F. Beigel, T. Olszak, K. Zitzmann, S. Eichhorst, J. Otte, H. Diepolder, A. Marquardt, W. Jagla, A. Popp, S. Leclair, K. Herrmann, J. Seiderer, T. Ochsenkuhn, B. Goke, C.J. Auernhammer, and J. Dambacher. 2006. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. American Journal of Physiology: Gastrointestinal and Liver Physiology 290: G827–G838.PubMed Brand, S., F. Beigel, T. Olszak, K. Zitzmann, S. Eichhorst, J. Otte, H. Diepolder, A. Marquardt, W. Jagla, A. Popp, S. Leclair, K. Herrmann, J. Seiderer, T. Ochsenkuhn, B. Goke, C.J. Auernhammer, and J. Dambacher. 2006. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. American Journal of Physiology: Gastrointestinal and Liver Physiology 290: G827–G838.PubMed
10.
Zurück zum Zitat Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa, K. Kitoh, S. Kim-Mitsuyama, A. Takayanagi, N. Shimizu, and Y. Fujiyama. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969–984.CrossRefPubMed Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa, K. Kitoh, S. Kim-Mitsuyama, A. Takayanagi, N. Shimizu, and Y. Fujiyama. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969–984.CrossRefPubMed
11.
Zurück zum Zitat Li, L.-J., C. Gong, M.-H. Zhao, and B.-S. Feng. 2014. Role of interleukin-22 in inflammatory bowel diseases. World Journal of Gastroenterology 20: 18177–18188.CrossRefPubMedPubMedCentral Li, L.-J., C. Gong, M.-H. Zhao, and B.-S. Feng. 2014. Role of interleukin-22 in inflammatory bowel diseases. World Journal of Gastroenterology 20: 18177–18188.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Wang, X., N. Ota, P. Manzanillo, L. Kates, J. Zvala-solorio, C. Eidenschenk, J. Zhang, J. Lesch, W.P. Lee, J. Ross, L. Diehl, L. van Bruggen, G. Kolumam, and W. Ouyang. 2014. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514: 237–241.PubMed Wang, X., N. Ota, P. Manzanillo, L. Kates, J. Zvala-solorio, C. Eidenschenk, J. Zhang, J. Lesch, W.P. Lee, J. Ross, L. Diehl, L. van Bruggen, G. Kolumam, and W. Ouyang. 2014. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514: 237–241.PubMed
13.
Zurück zum Zitat Lejeune, D., L. Dumoutier, S. Constantinescu, W. Kruijer, J. Schuringa, and J. Renauld. 2002. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line—Pathways that are shared with and distinct from IL-10. Journal of Biological Chemistry 277: 33676–33682.CrossRefPubMed Lejeune, D., L. Dumoutier, S. Constantinescu, W. Kruijer, J. Schuringa, and J. Renauld. 2002. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line—Pathways that are shared with and distinct from IL-10. Journal of Biological Chemistry 277: 33676–33682.CrossRefPubMed
14.
Zurück zum Zitat Wolk, K., E. Witte, E. Wallace, W. Docke, S. Kunz, K. Asadullah, H. Volk, W. Sterry, and R. Sabat. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. European Journal of Immunology 36: 1309–1323.CrossRefPubMed Wolk, K., E. Witte, E. Wallace, W. Docke, S. Kunz, K. Asadullah, H. Volk, W. Sterry, and R. Sabat. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. European Journal of Immunology 36: 1309–1323.CrossRefPubMed
15.
Zurück zum Zitat Rafferty, B.J., B.L. Unger, A.C. Perey, S.P. Tammariello, S. Pavlides, and D.W. McGee. 2012. A novel role for the Rho-Associated Kinase, ROCK, in IL-1-stimulated intestinal epithelial cell responses. Cellular Immunology 280: 148–155.CrossRefPubMed Rafferty, B.J., B.L. Unger, A.C. Perey, S.P. Tammariello, S. Pavlides, and D.W. McGee. 2012. A novel role for the Rho-Associated Kinase, ROCK, in IL-1-stimulated intestinal epithelial cell responses. Cellular Immunology 280: 148–155.CrossRefPubMed
16.
Zurück zum Zitat Treede, I., A. Braun, P. Jeliaskova, T. Giese, J. Fuellekrug, G. Griffiths, W. Stremmel, and R. Ehehalt. 2009. TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterology 9: 53–64.CrossRefPubMedPubMedCentral Treede, I., A. Braun, P. Jeliaskova, T. Giese, J. Fuellekrug, G. Griffiths, W. Stremmel, and R. Ehehalt. 2009. TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterology 9: 53–64.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Vitkus, S.J.D., S.A. Hanifin, and D.W. McGee. 1998. Factors affecting Caco-2 intestinal epithelial cell interleukin-6 secretion. In Vitro Cellular and Developmental Biology-Animal 34: 660–664.CrossRefPubMed Vitkus, S.J.D., S.A. Hanifin, and D.W. McGee. 1998. Factors affecting Caco-2 intestinal epithelial cell interleukin-6 secretion. In Vitro Cellular and Developmental Biology-Animal 34: 660–664.CrossRefPubMed
18.
Zurück zum Zitat Baud, V., Z.-G. Lie, B. Bennett, N. Suzuki, Y. Xia, and M. Karin. 1999. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes and Development 13: 1297–1308.CrossRefPubMedPubMedCentral Baud, V., Z.-G. Lie, B. Bennett, N. Suzuki, Y. Xia, and M. Karin. 1999. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes and Development 13: 1297–1308.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Hoffmann, E., O. Dittrich-Breiholz, H. Holtmann, and M. Kracht. 2002. Multiple control of interleukin-8 gene expression. Journal of Leukocyte Biology 72: 847–855.PubMed Hoffmann, E., O. Dittrich-Breiholz, H. Holtmann, and M. Kracht. 2002. Multiple control of interleukin-8 gene expression. Journal of Leukocyte Biology 72: 847–855.PubMed
21.
Zurück zum Zitat Cuadrado, A., and A.R. Nebreda. 2010. Mechanisms and functions of p38 MAPK signaling. Biochemistry Journal 429: 403–417.CrossRef Cuadrado, A., and A.R. Nebreda. 2010. Mechanisms and functions of p38 MAPK signaling. Biochemistry Journal 429: 403–417.CrossRef
22.
Zurück zum Zitat Hamilton, T., X. Li, M. Novotny, P.G. Pavicic Jr., S. Datta, C. Zhao, J. Hartupee, and D. Sun. 2012. Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression. Journal of Leukocyte Biology 91: 377–383.CrossRefPubMedPubMedCentral Hamilton, T., X. Li, M. Novotny, P.G. Pavicic Jr., S. Datta, C. Zhao, J. Hartupee, and D. Sun. 2012. Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression. Journal of Leukocyte Biology 91: 377–383.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Cargnello, M., and P.P. Roux. 2011. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiology and Molecular Biology Reviews 75: 50–83.CrossRefPubMedPubMedCentral Cargnello, M., and P.P. Roux. 2011. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiology and Molecular Biology Reviews 75: 50–83.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Liu, Q., A. Li, Y. Tian, J.D. Wu, Y. Liu, T. Li, Y. Chen, X. Han, and K. Wu. 2016. The CXCL8-CXCR1/2 pathways in cancer. Cytokine and Growth Factor Reviews 31: 61–71.CrossRefPubMed Liu, Q., A. Li, Y. Tian, J.D. Wu, Y. Liu, T. Li, Y. Chen, X. Han, and K. Wu. 2016. The CXCL8-CXCR1/2 pathways in cancer. Cytokine and Growth Factor Reviews 31: 61–71.CrossRefPubMed
Metadaten
Titel
IL-22 Enhances TNF-α- and IL-1-Induced CXCL8 Responses by Intestinal Epithelial Cell Lines
verfasst von
Rebecca S. Young
Brody M. Wiles
Dennis W. McGee
Publikationsdatum
27.06.2017
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2017
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0614-5

Weitere Artikel der Ausgabe 5/2017

Inflammation 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.